NO993465L - Adenoviral-vektor-formidlet gentransport inn i medulaere motoriske neuroner - Google Patents

Adenoviral-vektor-formidlet gentransport inn i medulaere motoriske neuroner

Info

Publication number
NO993465L
NO993465L NO993465A NO993465A NO993465L NO 993465 L NO993465 L NO 993465L NO 993465 A NO993465 A NO 993465A NO 993465 A NO993465 A NO 993465A NO 993465 L NO993465 L NO 993465L
Authority
NO
Norway
Prior art keywords
adenoviral vector
mediated gene
motor neurons
gene transport
medullary motor
Prior art date
Application number
NO993465A
Other languages
English (en)
Other versions
NO993465D0 (no
Inventor
Francoise Finiels
Minerva Gimenez-Ribotta
Jacques Mallet
Alain Privat
Frederic Revah
Original Assignee
Rhone Poulenc Rorer Sa
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/785,074 external-priority patent/US6632427B1/en
Application filed by Rhone Poulenc Rorer Sa, Inst Nat Sante Rech Med filed Critical Rhone Poulenc Rorer Sa
Publication of NO993465D0 publication Critical patent/NO993465D0/no
Publication of NO993465L publication Critical patent/NO993465L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO993465A 1997-01-17 1999-07-14 Adenoviral-vektor-formidlet gentransport inn i medulaere motoriske neuroner NO993465L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/785,074 US6632427B1 (en) 1994-12-13 1997-01-17 Adenoviral-vector-mediated gene transfer into medullary motor neurons
US4224797P 1997-03-31 1997-03-31
PCT/EP1998/000220 WO1998031395A1 (en) 1997-01-17 1998-01-16 Adenoviral-vector-mediated gene transfer into medullary motor neurons

Publications (2)

Publication Number Publication Date
NO993465D0 NO993465D0 (no) 1999-07-14
NO993465L true NO993465L (no) 1999-09-09

Family

ID=26719029

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993465A NO993465L (no) 1997-01-17 1999-07-14 Adenoviral-vektor-formidlet gentransport inn i medulaere motoriske neuroner

Country Status (11)

Country Link
US (1) US6552003B2 (no)
EP (1) EP0969875B1 (no)
JP (1) JP2002516607A (no)
AU (1) AU6614398A (no)
BR (1) BR9806912A (no)
CA (1) CA2277869A1 (no)
CZ (1) CZ250499A3 (no)
IL (1) IL130852A0 (no)
NO (1) NO993465L (no)
SK (1) SK95599A3 (no)
WO (1) WO1998031395A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE526981T1 (de) 2000-04-12 2011-10-15 Vib Vzw Verwendung von vegf 165 und homologen zur behandlung von neurologischen störungen
WO2003004660A1 (en) * 2001-07-03 2003-01-16 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods of administering vectors to synaptically connected neurons
EP1463530A4 (en) * 2001-12-19 2006-09-06 Lijun Wang ADENO-ASSOCIATED VIRUS-RELATED DELIVERY OF GDNF TO SKELETAL MUSCLES
US20050234000A1 (en) * 2003-12-12 2005-10-20 Mitchell Gordon S SiRNA delivery into mammalian nerve cells
ME01870B (me) 2004-05-27 2011-04-30 Vib Vzw Liječenje amiotrofične lateralne skleroze
US9078808B2 (en) * 2009-03-26 2015-07-14 Warsaw Orthopedic, Inc. Device to deliver magnesium in PEG formulation
WO2021163274A1 (en) * 2020-02-11 2021-08-19 The General Hospital Corporation Methods for treating amyotrophic lateral sclerosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
IL95511A (en) * 1989-08-30 2000-10-31 Max Planck Gesellschaft Neurotrophin-3 a novel neurotrophic factor related to nerve growth and brain derived neurotrophic factor
US5849571A (en) * 1990-10-10 1998-12-15 University Of Pittsburgh Of The Commonwealth System Of Higher Education Latency active herpes virus promoters and their use
FR2727867B1 (fr) * 1994-12-13 1997-01-31 Rhone Poulenc Rorer Sa Transfert de genes dans les motoneurones medullaires au moyen de vecteurs adenoviraux
AU2677797A (en) * 1996-04-25 1997-11-12 Genetic Therapy, Inc. Viral vectors including polynucleotides encoding neurotrophic factors and uses therefor

Also Published As

Publication number Publication date
WO1998031395A1 (en) 1998-07-23
NO993465D0 (no) 1999-07-14
EP0969875B1 (en) 2008-11-26
JP2002516607A (ja) 2002-06-04
AU6614398A (en) 1998-08-07
EP0969875A1 (en) 2000-01-12
BR9806912A (pt) 2000-05-16
CA2277869A1 (en) 1998-07-23
CZ250499A3 (cs) 1999-11-17
US20020164303A1 (en) 2002-11-07
IL130852A0 (en) 2001-01-28
US6552003B2 (en) 2003-04-22
SK95599A3 (en) 2000-05-16

Similar Documents

Publication Publication Date Title
IT1314250B1 (it) Proteine (iip) che interagiscono con il recettore igf-1 geni che lecodificano e loro impiego.
DE59909272D1 (de) Frachtladesystem
EP0989811A4 (en) PULL-UP TRANSPORT CASE
DE69832228D1 (de) Symmetrierschaltung
NO982097L (no) Peptider
NO982098D0 (no) Peptider
AU6173900A (en) Peptide transport
PT964856E (pt) Aminoacidos aromaticos biciclicos
DE59802359D1 (de) Transportsystem
NO984001D0 (no) Material-transportsystem
DE59808260D1 (de) Transporteinrichtung
AU5744200A (en) Human transport proteins
NO995062D0 (no) <Beta>-anyloidpeptid-bindende proteiner og polynuldeotider som kodes for samme
NO993465D0 (no) Adenovirus-vektor-formidlet gen transport inn i modullaere motoriske neuroner
FR2760712B1 (fr) Wagon porte-conteneurs
FI950317L (fi) Kationisten aminohappojen kuljetusproteiinia koodaava geeni
AUPO957397A0 (en) Transporter protein
DE69809796D1 (de) Rf-dreiwegkombinierer/-verteiler
EP1202741A4 (en) TRANSPORT OF NEUROTROPIC VIRUSES
DE59810392D1 (de) Taumelscheiben-Transportsystem
AU4245500A (en) Protein transport assays
IT237535Y1 (it) Rampa di carico perfezionata
DE69740133D1 (de) Patiententransportsystem
FI104159B1 (fi) Säiliörakenteen käsittävä kuljetusväline
DK0952069T3 (da) Transportanhænger

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application